Publications by authors named "Peter D Senter"

Claim this Profile
T
Targeted delivery of a potent STING agonist payload via an antibody drug conjugate drives robust antitumor activity in preclinical models.
David R Gruber, Elizabeth J Cummins, Weiping Zeng, Michelle Ulrich, Kaleb Smith, Peter D Senter

Mol Cancer Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Auristatin S: An Auristatin Payload with Improved Tolerability and Modified Bystander Activity.
Philip N Moquist, Nicole M-L Eng-Duncan, Tim D Bovee, Katie Snead, Lauren Bou, Peter D Senter

ACS Med Chem Lett· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Development of SGN-CD47M: Protease-Activated Antibody Technology Enables Selective Tumor Targeting of the Innate Immune Checkpoint Receptor CD47.
Matthew R Levengood, Christopher M Carosino, Xinqun Zhang, Sasha Lucas, David J Ortiz, Peter D Senter

Mol Cancer Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversible Chemical Modification of Antibody Effector Function Mitigates Unwanted Systemic Immune Activation.
Philip N Moquist, Xinqun Zhang, Chris I Leiske, Nicole M-L Eng-Duncan, Weiping Zeng, Peter D Senter

Bioconjug Chem· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-drug conjugates come of age in oncology.
Charles Dumontet, Janice M Reichert, Peter D Senter, John M Lambert, Alain Beck

Nat Rev Drug Discov· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision cancer targeting with antibody pairs.
Robert T Lawrence, Peter D Senter

Nat Biotechnol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Antibody-Tubulysin Conjugates through Linker Chemistry and Site-Specific Conjugation.
Joseph Z Hamilton, Thomas A Pires, Jamie A Mitchell, Julia H Cochran, Kim K Emmerton, Peter D Senter

ChemMedChem· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Novel Antibody-Camptothecin Conjugates.
Ryan D Lyski, Lauren B Bou, Uland Y Lau, David W Meyer, Julia H Cochran, Peter D Senter

Mol Cancer Ther· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Auristatins with High Bystander and Cytotoxic Activities in Drug Efflux-positive Tumor Models.
Philip N Moquist, Tim D Bovee, Andrew B Waight, Jamie A Mitchell, Jamie B Miyamoto, Peter D Senter

Mol Cancer Ther· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships of tubulysin analogues.
Joel R Courter, Joseph Z Hamilton, Nathaniel R Hendrick, Margo Zaval, Andrew B Waight, Peter D Senter

Bioorg Med Chem Lett· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic and Prophylactic Antitumor Activity of an Oral Inhibitor of Fucosylation in Spontaneous Mammary Cancers.
Mary L Disis, Lauren R Corulli, Ekram A Gad, Marlese R Koehnlein, Denise L Cecil, Peter D Senter

Mol Cancer Ther· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breaking up is hard to do.
Heather A Van Epps, Peter D Senter

Nat Chem Biol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A coiled-coil masking domain for selective activation of therapeutic antibodies.
Vivian H Trang, Xinqun Zhang, Roma C Yumul, Weiping Zeng, Ivan J Stone, Peter D Senter

Nat Biotechnol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Delivery of Cytotoxic NAMPT Inhibitors Using Antibody-Drug Conjugates.
Christopher S Neumann, Kathleen C Olivas, Martha E Anderson, Julia H Cochran, Steven Jin, Peter D Senter

Mol Cancer Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lactone Stabilization is Not a Necessary Feature for Antibody Conjugates of Camptothecins.
Uland Y Lau, Lauren T Benoit, Nicole S Stevens, Kim K Emmerton, Margo Zaval, Peter D Senter

Mol Pharm· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucuronide-Linked Antibody-Tubulysin Conjugates Display Activity in MDR and Heterogeneous Tumor Models.
Patrick J Burke, Joseph Z Hamilton, Thomas A Pires, Holden W H Lai, Christopher I Leiske, Peter D Senter

Mol Cancer Ther· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of SGN-CD123A, A Potent CD123-Directed Antibody-Drug Conjugate for Acute Myeloid Leukemia.
Fu Li, May Kung Sutherland, Changpu Yu, Roland B Walter, Lori Westendorf, Peter D Senter

Mol Cancer Ther· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orthogonal Cysteine Protection Enables Homogeneous Multi-Drug Antibody-Drug Conjugates.
Matthew R Levengood, Xinqun Zhang, Joshua H Hunter, Kim K Emmerton, Jamie B Miyamoto, Peter D Senter

Angew Chem Int Ed Engl· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of a PEGylated Glucuronide-Monomethylauristatin E Linker for Antibody-Drug Conjugates.
Patrick J Burke, Joseph Z Hamilton, Scott C Jeffrey, Joshua H Hunter, Svetlana O Doronina, Peter D Senter

Mol Cancer Ther· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutting back on the carbs.
Vivian H Trang, Peter D Senter

Proc Natl Acad Sci U S A· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Methylene Alkoxy Carbamate Self-Immolative Unit: Utilization for the Targeted Delivery of Alcohol-Containing Payloads with Antibody-Drug Conjugates.
Robert V Kolakowski, Karl T Haelsig, Kim K Emmerton, Chris I Leiske, Jamie B Miyamoto, Peter D Senter

Angew Chem Int Ed Engl· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Novel Quaternary Ammonium Linkers for Antibody-Drug Conjugates.
Patrick J Burke, Joseph Z Hamilton, Thomas A Pires, Jocelyn R Setter, Joshua H Hunter, Peter D Senter

Mol Cancer Ther· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice.
John D Belcher, Chunsheng Chen, Julia Nguyen, Fuad Abdulla, Phong Nguyen, Peter D Senter

PLoS One· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index.
Robert P Lyon, Tim D Bovee, Svetlana O Doronina, Patrick J Burke, Joshua H Hunter, Peter D Senter

Nat Biotechnol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates.
Robert P Lyon, Jocelyn R Setter, Tim D Bovee, Svetlana O Doronina, Joshua H Hunter, Peter D Senter

Nat Biotechnol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis